ZA936504B - Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. - Google Patents

Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure.

Info

Publication number
ZA936504B
ZA936504B ZA936504A ZA936504A ZA936504B ZA 936504 B ZA936504 B ZA 936504B ZA 936504 A ZA936504 A ZA 936504A ZA 936504 A ZA936504 A ZA 936504A ZA 936504 B ZA936504 B ZA 936504B
Authority
ZA
South Africa
Prior art keywords
eye
intraocular pressure
topical application
pharmaceutical composition
increased intraocular
Prior art date
Application number
ZA936504A
Other languages
English (en)
Inventor
Helmut Franz
Hannes Edgar Kompa
Tibor Rozman
Original Assignee
Basotherm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basotherm Gmbh filed Critical Basotherm Gmbh
Publication of ZA936504B publication Critical patent/ZA936504B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
ZA936504A 1992-09-04 1993-09-03 Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. ZA936504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4229494A DE4229494A1 (de) 1992-09-04 1992-09-04 Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks

Publications (1)

Publication Number Publication Date
ZA936504B true ZA936504B (en) 1995-03-03

Family

ID=6467184

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936504A ZA936504B (en) 1992-09-04 1993-09-03 Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure.

Country Status (19)

Country Link
US (1) US5527831A (ja)
EP (1) EP0585896B1 (ja)
JP (1) JPH06172158A (ja)
KR (1) KR940006575A (ja)
CN (1) CN1086132A (ja)
AT (1) ATE145823T1 (ja)
AU (1) AU673533B2 (ja)
CA (1) CA2105530A1 (ja)
CZ (1) CZ284095B6 (ja)
DE (2) DE4229494A1 (ja)
DK (1) DK0585896T3 (ja)
ES (1) ES2096161T3 (ja)
GR (1) GR3022225T3 (ja)
HU (1) HU213272B (ja)
NO (1) NO933140L (ja)
NZ (1) NZ248567A (ja)
PL (1) PL300286A1 (ja)
SK (1) SK79893A3 (ja)
ZA (1) ZA936504B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
MY128762A (en) 2001-01-12 2007-02-28 Novartis Ag Lens care product containing dexpanthenol
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2005035969A (ja) * 2003-06-25 2005-02-10 Lion Corp 眼科用組成物及び該組成物の安定化方法
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
US9911989B2 (en) * 2005-07-25 2018-03-06 Bloom Energy Corporation Fuel cell system with partial recycling of anode exhaust
AU2008238577B2 (en) * 2007-04-12 2015-02-19 Waratah Pharmaceuticals Inc. Use of cyclohexanehexol derivatives in the treatment of ocular diseases
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
HUE049489T2 (hu) 2011-12-07 2020-09-28 Allergan Inc Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
PT72703B (en) * 1980-03-21 1982-11-15 Wellcome Found Stabilised ophtalmic formulation
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.

Also Published As

Publication number Publication date
AU4610593A (en) 1994-03-10
NZ248567A (en) 1995-11-27
ES2096161T3 (es) 1997-03-01
CZ181193A3 (en) 1994-07-13
GR3022225T3 (en) 1997-04-30
AU673533B2 (en) 1996-11-14
KR940006575A (ko) 1994-04-25
NO933140D0 (no) 1993-09-03
HUT64836A (en) 1994-03-28
SK79893A3 (en) 1994-08-10
EP0585896B1 (de) 1996-12-04
HU9302502D0 (en) 1993-11-29
ATE145823T1 (de) 1996-12-15
CZ284095B6 (cs) 1998-08-12
NO933140L (no) 1994-03-07
DE4229494A1 (de) 1994-03-10
HU213272B (en) 1997-04-28
JPH06172158A (ja) 1994-06-21
PL300286A1 (en) 1994-03-07
US5527831A (en) 1996-06-18
EP0585896A1 (de) 1994-03-09
CN1086132A (zh) 1994-05-04
CA2105530A1 (en) 1994-03-05
DE59304658D1 (de) 1997-01-16
DK0585896T3 (da) 1997-04-14

Similar Documents

Publication Publication Date Title
ZA936504B (en) Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure.
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
DK54390D0 (da) Okularcyklosporinpraeparat
IE811654L (en) Ophthalmic composition
EP0470127A4 (en) Pcp receptor ligands and the use thereof
EP0834320A4 (en) ACTIVE COMPOSITION COMPOSED BY ALBUMIN AS AN ACTIVE INGREDIENT
AR011192A1 (es) Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma
ES2032390T3 (es) Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).
ES2127375T3 (es) Procedimiento de administracion de un farmaco oftalmico.
TW266154B (ja)
ES2141736T3 (es) Gel, especialmente para uso terapeutico ocular.
CA2294207A1 (en) Anti-chlamydia agent
CA2025728A1 (en) Antimicrobial compositions
BR9813855A (pt) Uso de flunarizina, ou de um seu sal farmaceuticamente aceitável, e, composição oftálmica tópica para o tratamento e/ou a profilaxia do glaucoma
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
PT92538A (pt) Processo para a formulacao para o conforto do olho para terapeutica do glaucoma, compreendendo inter alia um polimero mucomimetrico anionico
IT1272740B (it) Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da diabete mellito
KR950000161A (ko) 녹농균 감염증 치료제 및 예방백신을 제조하기 위한 약독화 녹농균주 cfcpa 50243의 용도
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
ES246200U (es) Dispositivo desatascador por inyeccion a presion